Monash IVF Group Limited

MVF

AU000000MVF3

Healthcare Facilities & Services

Delayed Australian S.E. Other stock markets 09:39:40 2024-06-13 pm EDT			5-day change	1st Jan Change
1.35 ^AUD	-1.10%		+1.12%	+3.85%

Apr. 30	Wilsons Upgrades Monash IVF to Overweight from Market-Weight, Price Target is AU$1.58	MT
Apr. 12	RBC Capital Markets Starts Monash IVF Group at New Sector Perform, Price Target is AU$1.50	MT

Monash IVF Group Limited Announces Resignation of Christina Boyce as Non-Executive Director

June 28, 2020 at 08:09 pm EDT

Monash IVF Group Limited announced that Ms. Christina (Christy) Boyce has tendered her resignation as a non-executive director of Monash IVF Group Limited.

Latest news about Monash IVF Group Limited

Wilsons Upgrades Monash IVF to Overweight from Market-Weight, Price Target is AU$1.58	Apr. 29	MT
RBC Capital Markets Starts Monash IVF Group at New Sector Perform, Price Target is AU$1.50	Apr. 11	MT
Monash IVF Group Limited(ASX:MVF) added to S&P/ASX Small Ordinaries Index	Mar. 17	CI
Monash IVF Group Limited(ASX:MVF) added to S&P/ASX 300 Index	Mar. 17	CI
Morgan Stanley Adjusts Monash IVF Group’s Price Target to AU$1.65 From AU$1.45, Keeps at Overweight	Mar. 05	MT
Monash IVF Group Completes Fertility North Acquisition	Mar. 03	MT
Monash IVF Group Limitedcompleted the acquisition of 80% stake in Fertility North Holdings Pty Ltd.	Mar. 03	CI
Monash IVF Group Limited Appoints Cathy Aston as an Independent Non-Executive Director and A Member of the Audit and Risk Management Committee Effective from 26 February 2024	Feb. 25	CI
Monash IVF Group Shares Fall 3% Despite EPS Growth in H1 FY24 on 22% Revenue Jump	Feb. 22	MT
Transcript : Monash IVF Group Limited, H1 2024 Earnings Call, Feb 23, 2024	Feb. 22
Monash IVF Group Reports H1 FY24 Revenue Up 22% to AU$125.7 Million; EPS of AU$0.033	Feb. 22	MT
Monash IVF Reports Half Year FY24 Revenue Up 21.7% to AU$125.7 Million; EPS of AU$0.033	Feb. 22	MT
Monash IVF Group Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 22	CI
Competition Regulator Clears Monash IVF Group's Acquisition of Fertility North	Feb. 22	MT
Monash Ivf Group Acquiring Perth-based Fertility Services Provider	Dec. 18	MT
Monash IVF Group Limited entered into Share Sale Agreement to acquire 80% stake in Fertility North Holdings Pty Ltd.	Dec. 18	CI
Transcript : Monash IVF Group Limited - Shareholder/Analyst Call	Nov. 27
Monash IVF Group Limited Announces Fully Franked Final Dividend for Fiscal Year Ended June 30, 2023, Payable on 11 October 2023	23-08-21	CI
Monash IVF Group Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-21	CI
Monash IVF Group Limited completed the acquisition of PIVET Medical Centre.	23-05-28	CI
Monash IVF Group Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended December 31, 2022, Payable on April 7, 2023	23-02-20	CI
Monash IVF Group Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-20	CI
Transcript : Monash IVF Group Limited - Shareholder/Analyst Call	22-11-10
Monash IVF Acquires ART Associates Queensland	22-09-29	MT
Monash IVF Group Limited completed the acquisition of ART Associates Queensland #2 Pty Ltd.	22-09-29	CI

Chart Monash IVF Group Limited

Duration

Period

More charts

Monash IVF Group Limited is an Australia-based company, which is primarily involved in assisted reproductive services. The Company is also a provider of specialist womenâs imaging services. It operates through two segments: Monash IVF Group Australia and Monash IVF Group International. The Monash IVF Group Australia segment provides assisted reproductive services, ultrasound, and other related services. The Monash IVF Group International segment provides assisted reproductive services in Southeast Asia. The Company's business includes Fertility Solutions that provide fertility treatment and care; KL Fertility is a fertility specialist center; Monash IVF is a fertility research and treatment center; Monash IVF KPJ Johor is a full-service hospital-based fertility center, and Monash Ultrasound for Women provides tertiary level prenatal diagnostic services. Its business also includes Repromed and Sydney Ultrasound for Women.

Sector

Healthcare Facilities & Services

Calendar

2024-08-21 - Q4 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Monash IVF Group Limited

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.365 AUD

Average target price

1.541 AUD

Spread / Average Target

+12.88%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
MONASH IVF GROUP LIMITED	+3.85%	347M
HCA HEALTHCARE, INC.	+25.94%	89.26B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+3.24%	27.41B
FRESENIUS SE & CO. KGAA	+6.63%	18.36B
LABCORP HOLDINGS INC.	-13.56%	16.55B
QUEST DIAGNOSTICS INCORPORATED	+0.47%	15.42B
NATERA, INC.	+76.87%	13.83B
TENET HEALTHCARE CORPORATION	+84.57%	13.75B
FRESENIUS MEDICAL CARE AG	+1.95%	12.75B
PURE HEALTH HOLDING	-26.49%	12.64B

Other Healthcare Facilities & Services